Madison N Irwin (Madison Irwin)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Peritoneal Dialysis

Cross Sectional

Top Venues

Journal of pain & palliative care pharmacotherapy

Clinical and translational science

Journal of pharmacy practice

The mental health clinician

This page only lists publications with an associated author ORCID identifier.

Publications

Madison N Irwin, David A Cooke, Daniel Berland, Vincent D Marshall, Michael A Smith
Efficacy and Safety of Low Dose Naltrexone for Chronic Pain. Journal of pain & palliative care pharmacotherapy 38 (1) (2024)
Madison N Irwin, David A Cooke, Daniel Berland, Vincent D Marshall, Michael A Smith
Efficacy and Safety of Low Dose Naltrexone for Chronic Pain. Journal of pain & palliative care pharmacotherapy 38 (1) (2024)
Madison N Irwin, David A Cooke, Daniel Berland, Vincent D Marshall, Michael A Smith
Efficacy and Safety of Low Dose Naltrexone for Chronic Pain. Journal of pain & palliative care pharmacotherapy (2024)
Madison N Irwin, David A Cooke, Daniel Berland, Vincent D Marshall, Michael A Smith
Efficacy and Safety of Low Dose Naltrexone for Chronic Pain. Journal of pain & palliative care pharmacotherapy 38 (1) (2024)
Madison N Irwin, Michael A Smith
Validation of ICD-9 Codes for Identification of Chronic Overlapping Pain Conditions. Journal of pain & palliative care pharmacotherapy 36 (3) (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science 16 (2) (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science 16 (2) (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science 16 (2) (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science 16 (2) (2022)
Madison N Irwin, Sarah Adie, Katherine Sandison, Sarah A Alsomairy, Adamo Brancaccio
Warfarin Dose Requirements in Adults Hospitalized With COVID-19 Infection: A Retrospective Case Series. Journal of pharmacy practice (2021)
Madison N Irwin, Kyle Quirk, Andrea Banner, Kevin Hosseini, Michael A Smith
Strategies for Rotation between Gabapentinoids in the Inpatient Setting. Journal of pain & palliative care pharmacotherapy 35 (1) (2021)
Madison N Irwin, Amy M VandenBerg
Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action. The mental health clinician 11 (3) (2021)